GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mycenax Biotech Inc (ROCO:4726) » Definitions » Debt-to-Revenue

Mycenax Biotech (ROCO:4726) Debt-to-Revenue : 1.14 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mycenax Biotech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Mycenax Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$200.0 Mil. Mycenax Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$683.4 Mil. Mycenax Biotech's annualized Revenue for the quarter that ended in Dec. 2024 was NT$776.0 Mil. Mycenax Biotech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 1.14.


Mycenax Biotech Debt-to-Revenue Historical Data

The historical data trend for Mycenax Biotech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycenax Biotech Debt-to-Revenue Chart

Mycenax Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.96 1.31 1.11 1.29

Mycenax Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 2.27 1.15 1.10 1.14

Competitive Comparison of Mycenax Biotech's Debt-to-Revenue

For the Biotechnology subindustry, Mycenax Biotech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycenax Biotech's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mycenax Biotech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mycenax Biotech's Debt-to-Revenue falls into.



Mycenax Biotech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Mycenax Biotech's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(199.991 + 683.401) / 683.924
=1.29

Mycenax Biotech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(199.991 + 683.401) / 775.972
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Mycenax Biotech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mycenax Biotech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycenax Biotech Business Description

Traded in Other Exchanges
N/A
Address
No.66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.

Mycenax Biotech Headlines

No Headlines